Advertisement

Journal of Gastrointestinal Surgery

, Volume 21, Issue 3, pp 560–568 | Cite as

Outcomes of Primary Colorectal Sarcoma: A National Cancer Data Base (NCDB) Review

  • Cornelius A. Thiels
  • John R. Bergquist
  • Adam C. Krajewski
  • Hee Eun Lee
  • Heidi Nelson
  • Kellie L. Mathis
  • Elizabeth B. Habermann
  • Robert R. CimaEmail author
Original Article

Abstract

Introduction

Primary colorectal sarcomas are a rare entity with anecdotally poor outcomes. We sought to inform surgeons, oncologists, and researchers of the characteristics and outcomes of these understudied and difficult-to-manage tumors.

Methods

The National Cancer Data Base (NCDB) was queried for patients with pathologically confirmed primary sarcoma of the colon or rectum (1998–2012). Gastrointestinal stromal tumors were excluded. Unadjusted overall survival was reported using the Kaplan-Meier method. Patients with colorectal adenocarcinoma were used as a comparison cohort.

Results

Four hundred thirty-three patients with primary colorectal sarcoma were identified (57.5% leiomyosarcoma subtype). Median age was 63 [inter-quartile range 52, 75] years with 23.1% between the ages of 18 and 50 and 48.7% female. Majority of sarcomas were located in the colon (70.7%). When compared to 696,902 patients with adenocarcinoma, sarcoma patients were younger, had larger tumors, were more likely node negative and rectal in location, and higher grade (all p < 0.001), while sex, race, and comorbidity score were similar (all p > 0.05). Overall survival was lower at 5 years in patients with sarcoma (43.8%) than adenocarcinoma (52.3%, p < 0.001).

Conclusion

Primary colorectal sarcomas are rare and present at a younger age and higher grade than adenocarcinoma of the colon and rectum. Survival is significantly worse compared to adenocarcinoma patients.

Keywords

Sarcoma Colorectal cancer National Cancer Database Leiomyosarcoma 

Notes

Acknowledgements

The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery provided support for this work.

Author Contribution

All authors contributed to the study design and interpretation of the data. Thiels, Bergquist, Habermann, and Cima contributed to the data acquisition and analysis. All authors contributed to the drafting, critical review, and final approval of the manuscript and agree to be held accountable for all aspects of the work.

Compliance with Ethical Standards

Conflicts of Interest and Source of Funding

The authors have no relevant financial disclosures.

References

  1. 1.
    Cuffy M, Abir F, Longo WE. Management of less common tumors of the colon, rectum, and anus. Clin. Colorectal Cancer 2006;5:327–337.CrossRefPubMedGoogle Scholar
  2. 2.
    Yaren A, Değirmencioğlu S, Callı Demirkan N, et al. Primary mesenchymal tumors of the colon: a report of three cases. Turk. J. Gastroenterol 2014;25:314–318.CrossRefPubMedGoogle Scholar
  3. 3.
    Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic variables.Ann. Surg. Oncol 1995;2:26–31.CrossRefPubMedGoogle Scholar
  4. 4.
    Chou CL, Chang SC, Lin TC, Chen WS, Jiang JK, Wang HS, Yang SH, Li, AF, Lin JK. Clinical analysis and surgical results of primary colorectal sarcoma. J Soc Colon Rectal Surg (Taiwan) 2010:161–168.Google Scholar
  5. 5.
    Yang J-L, Crowe PJ. Targeted therapies in adult soft tissue sarcomas. J Surg Oncol 2007;95:183–184.CrossRefPubMedGoogle Scholar
  6. 6.
    Luna-Pérez P, Rodríguez DF, Luján L, Alvarado I, Kelly J, Rojas ME, Labastida S, González JL. Colorectal sarcoma: analysis of failure patterns. J Surg Oncol 1998;69:36–40.CrossRefPubMedGoogle Scholar
  7. 7.
    Meijer S, Peretz T, Gaynor JJ, Tan C, Hajdu SI, Brennan MF. Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients. Arch Surg 1990;125:1163–1168.CrossRefPubMedGoogle Scholar
  8. 8.
    Diamante M, Bacon HE. Leiomyosarcoma of the rectum: report of a case. Dis Colon Rectum 1967;10:347–351.CrossRefPubMedGoogle Scholar
  9. 9.
    Khalifa AA, Bong WL, Rao VK, Williams MJ. Leiomyosarcoma of the rectum. Report of a case and review of the literature. Dis Colon Rectum 1986;29:427–432.CrossRefPubMedGoogle Scholar
  10. 10.
    Hishida Y, Ishida M. Smooth-muscle tumors of the rectum in Japanese. Dis Colon Rectum 1974; 7:226–234.CrossRefGoogle Scholar
  11. 11.
    Randleman CD, Wolff BG, Dozois RR, Spencer RJ, Weiland LH, Ilstrup DM. Leiomyosarcoma of the rectum and anus. A series of 22 cases. Int J Colorectal Dis 1989;4:91–96.CrossRefPubMedGoogle Scholar
  12. 12.
    Minsky BD, Cohen AM, Hajdu SI, Nori D. Sphincter preservation in rectal sarcoma. Dis Colon Rectum 1990;33:319–322.CrossRefPubMedGoogle Scholar
  13. 13.
    Martín Liberal J, Lagares-Tena L, Sáinz-Jaspeado M, Mateo-Lozano S, García Del Muro X, Tirado OM. Targeted therapies in sarcomas: challenging the challenge. Sarcoma 2012:626094.Google Scholar
  14. 14.
    Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009 Jun 15;99(8):488-490.Google Scholar
  15. 15.
    Radons J. The role of inflammation in sarcoma. Adv. Exp Med Biol 2014;816:259–313.CrossRefPubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2017

Authors and Affiliations

  • Cornelius A. Thiels
    • 1
    • 2
  • John R. Bergquist
    • 1
    • 2
  • Adam C. Krajewski
    • 1
  • Hee Eun Lee
    • 3
  • Heidi Nelson
    • 4
  • Kellie L. Mathis
    • 4
  • Elizabeth B. Habermann
    • 2
  • Robert R. Cima
    • 4
    Email author
  1. 1.Department of SurgeryMayo ClinicRochesterUSA
  2. 2.Robert D. and Patricia E. Kern Center for the Science of Healthcare DeliveryMayo ClinicRochesterUSA
  3. 3.Laboratory Medicine and PathologyMayo ClinicRochesterUSA
  4. 4.Division of Colon and Rectal Surgery, Department of SurgeryMayo ClinicRochesterUSA

Personalised recommendations